Bluejay Diagnostics, Inc.
BJDX
$1.17
-$0.05-4.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.96M | 3.94M | 3.71M | 3.70M | 3.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.98M | 6.72M | 6.63M | 7.17M | 8.07M |
| Operating Income | -6.98M | -6.72M | -6.63M | -7.17M | -8.07M |
| Income Before Tax | -6.85M | -6.74M | -7.25M | -7.72M | -8.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.85 | -6.74 | -7.25 | -7.72 | -8.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.85M | -6.74M | -7.25M | -7.72M | -8.59M |
| EBIT | -6.98M | -6.72M | -6.63M | -7.17M | -8.07M |
| EBITDA | -6.91M | -6.65M | -6.56M | -7.09M | -7.99M |
| EPS Basic | -33.60 | -109.53 | -108.12 | -104.76 | -76.94 |
| Normalized Basic EPS | -5.32 | -9.53 | -8.65 | -6.55 | -4.85 |
| EPS Diluted | -33.60 | -109.53 | -108.12 | -104.76 | -76.94 |
| Normalized Diluted EPS | -5.32 | -9.53 | -8.65 | -6.55 | -4.85 |
| Average Basic Shares Outstanding | 4.04M | 2.66M | 1.27M | 718.00K | 191.10K |
| Average Diluted Shares Outstanding | 4.04M | 2.66M | 1.27M | 718.00K | 191.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |